Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.
作者信息
Lip Gregory Y H
机构信息
University Department of Medicine, City Hospital, Birmingham B18 7QH.
出版信息
BMJ. 2008 Mar 15;336(7644):614-5. doi: 10.1136/bmj.39351.706586.AD.
Abstract
摘要
相似文献
1
Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.
BMJ. 2008 Mar 15;336(7644):614-5. doi: 10.1136/bmj.39351.706586.AD.
2
[Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence].
Arch Cardiol Mex. 2012 Jul-Sep;82(3):248-51. doi: 10.1016/j.acmx.2012.03.002. Epub 2012 Sep 14.
3
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4.
4
Who is ineligible for warfarin in atrial fibrillation?
Lancet. 2009 Aug 15;374(9689):510-1. doi: 10.1016/S0140-6736(09)61471-9.
5
Warfarin, aspirin, and atrial fibrillation.
Harv Heart Lett. 1998 Aug;8(12):4-6.
6
Atrial fibrillation and anticoagulation.
Med Health R I. 2001 Mar;84(3):96-7.
7
[The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
Fortschr Neurol Psychiatr. 2008 Jul;76(7):383-4. doi: 10.1055/s-2008-1038167.
8
Aspirin in stroke prevention in nonvalvular atrial fibrillation and stable vascular disease: an era of new anticoagulants.
Expert Rev Cardiovasc Ther. 2012 Apr;10(4):433-9. doi: 10.1586/erc.12.19.
9
Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.
West J Med. 1995 Aug;163(2):177-9.
10
Prevention of vascular events in atrial fibrillation.
Lancet. 2007 Jan 13;369(9556):105-6; author reply 106. doi: 10.1016/S0140-6736(07)60067-1.
引用本文的文献
1
Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.
BMJ. 2015 Nov 16;351:h5876. doi: 10.1136/bmj.h5876.
2
Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis.
PLoS One. 2015 Nov 12;10(11):e0142222. doi: 10.1371/journal.pone.0142222. eCollection 2015.
3
Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
Clin Interv Aging. 2014 Jul 15;9:1091-9. doi: 10.2147/CIA.S62597. eCollection 2014.
4
Stroke prevention: an update.
Front Med. 2012 Mar;6(1):22-34. doi: 10.1007/s11684-012-0178-6. Epub 2012 Mar 31.
5
Atrial fibrillation and vascular disease--a bad combination.
Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):15-20. doi: 10.1002/clc.20955.
6
[Antithrombotic and anticoagulation therapy after stroke and transient ischemic attacks].
Nervenarzt. 2010 Dec;81(12):1509-17; quiz 1518-9. doi: 10.1007/s00115-010-3133-2.
7
Stroke prevention in atrial fibrillation: putting the guidelines into practice.
Drugs Aging. 2010 Nov 1;27(11):859-70. doi: 10.2165/11538620-000000000-00000.
8
[Anticoagulation in the elderly].
Internist (Berl). 2010 Nov;51(11):1446-55. doi: 10.1007/s00108-010-2702-6.
本文引用的文献
1
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
Eur Heart J. 2007 Mar;28(6):726-32. doi: 10.1093/eurheartj/ehl488. Epub 2007 Jan 31.
2
Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials.
Arch Intern Med. 2007 Jan 22;167(2):117-24. doi: 10.1001/archinte.167.2.117.
3
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
Chest. 2006 Dec;130(6):1823-7. doi: 10.1378/chest.130.6.1823.
4
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Am Heart J. 2006 Nov;152(5):967-73. doi: 10.1016/j.ahj.2006.06.024.
5
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.
Circulation. 2006 Jul 11;114(2):119-25. doi: 10.1161/CIRCULATIONAHA.105.595140. Epub 2006 Jul 3.
6
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4.
7
Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2006 Jul;68(1):56-61. doi: 10.1002/ccd.20733.
8
Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
J Invasive Cardiol. 2006 Apr;18(4):162-4.
9
Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?
Thromb Res. 2006;118(4):429-32. doi: 10.1016/j.thromres.2005.09.012. Epub 2005 Nov 7.
10
Antithrombotic treatment in atrial fibrillation.
Heart. 2006 Feb;92(2):155-61. doi: 10.1136/hrt.2005.066944. Epub 2005 Sep 13.
Zotero 插件